Cardiovascular Disease- Treatment
Receive compensation up to $2,870.
Evaluate if inclisiran will prevent cardiovascular events in participants.
Qualified Participants:
- Adults aged 40-79
- At a high cardiovascular risk for a first major adverse cardiovascular event
- Elevated cholesterol
